PRIMACOR Drug Patent Profile

Name: PRIMACOR Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Primacor patents expire, and when can generic versions of Primacor launch?

Primacor is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in PRIMACOR is milrinone lactate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Primacor

A generic version of PRIMACOR was approved as milrinone lactate by FRESENIUS KABI USA on May 28^th, 2002.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PRIMACOR?
What are the global sales for PRIMACOR?
What is Average Wholesale Price for PRIMACOR?

Summary for PRIMACOR

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	102
Clinical Trials:	11
Patent Applications:	4,265
DailyMed Link:	PRIMACOR at DailyMed

Drug patent expirations by year for PRIMACOR

Recent Clinical Trials for PRIMACOR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mahidol University	Phase 2
Zagazig University	Phase 4
Vanderbilt University Medical Center	Phase 1

See all PRIMACOR clinical trials

US Patents and Regulatory Information for PRIMACOR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi Aventis Us	PRIMACOR	milrinone lactate	INJECTABLE;INJECTION	019436-001	Dec 31, 1987		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-003	Aug 9, 1994		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-001	Aug 9, 1994		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-002	Aug 9, 1994		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sanofi Aventis Us	PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	020343-004	Aug 9, 1994		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for PRIMACOR

See the table below for patents covering PRIMACOR around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Argentina	230029	BOGIE DE VAGON FERROVIARIO	⤷ Start Trial
Austria	379386		⤷ Start Trial
Austria	379387		⤷ Start Trial
Austria	A143781		⤷ Start Trial
Austria	A578080		⤷ Start Trial
Austria	A95983		⤷ Start Trial
Australia	2475384		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

AI Deep Research

Questions you can ask:

Summary for PRIMACOR

Recent Clinical Trials for PRIMACOR

Make Better Decisions: Try a trial or see plans & pricing